Although BPH is not considered a risk factor for PCa [64], both diseases share common risk factors [19, 65], and benefit from some similar therapeutic agents, such as COX-2 inhibitors [66, 67]. The gene discussed is PTGS2; the disease is benign prostatic hyperplasia.